PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$71.1M
AUM Growth
+$4.73M
Cap. Flow
-$212K
Cap. Flow %
-0.3%
Top 10 Hldgs %
34.33%
Holding
121
New
39
Increased
28
Reduced
18
Closed
35
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$1.64M
2
ELV icon
Elevance Health
ELV
+$1.57M
3
HCA icon
HCA Healthcare
HCA
+$1.56M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.45M
5
UHS icon
Universal Health Services
UHS
+$1.25M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$1.68M
2
MCK icon
McKesson
MCK
+$1.54M
3
PFE icon
Pfizer
PFE
+$1.38M
4
SYK icon
Stryker
SYK
+$1.34M
5
GILD icon
Gilead Sciences
GILD
+$1.16M

Sector Composition

Rank Sector Weight
1 Healthcare 57.47%
2 Technology 9.06%
3 Communication Services 7.08%
4 Miscellaneous 7.02%
5 Industrials 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
$4.13M 5.8%
46,974
+6,176
+15% +$529K
2013 Q2
8 quarters
HCA icon
2
HCA Healthcare
HCA
$102B
$3.41M 4.8%
37,602
+19,515
+108% +$1.56M
2013 Q2
8 quarters
WBA icon
3
DELISTED
Walgreens Boots Alliance
WBA
$2.48M 3.49%
29,366
+3,848
+15% +$332K
2014 Q4
2 quarters
BMY icon
4
Bristol-Myers Squibb
BMY
$121B
$2.4M 3.38%
36,142
+21,973
+155% +$1.45M
2015 Q1
1 quarter
EW icon
5
Edwards Lifesciences
EW
$49.8B
$2.35M 3.3%
98,952
+28,002
+39% +$632K
2014 Q4
2 quarters
AER icon
6
AerCap
AER
$22.7B
$2.25M 3.17%
49,184
+17,087
+53% +$810K
2015 Q1
1 quarter
BRCM
7
DELISTED
BROADCOM CORP CL-A
BRCM
$2.21M 3.11%
43,010
+8,034
+23% +$391K
2014 Q4
2 quarters
AET
8
DELISTED
Aetna Inc
AET
$1.83M 2.58%
+14,390
New +$1.64M
2015 Q2
0 quarters
LBTYK icon
9
Liberty Global Class C
LBTYK
$2.74B
$1.68M 2.36%
40,967
+20,879
+104% +$865K
2014 Q4
2 quarters
VMC icon
10
Vulcan Materials
VMC
$31.3B
$1.66M 2.34%
19,824
-8,708
-31% -$759K
2014 Q1
5 quarters
HUM icon
11
Humana
HUM
$51.3B
$1.61M 2.27%
8,426
+943
+13% +$175K
2013 Q3
7 quarters
ELV icon
12
Elevance Health
ELV
$92.8B
$1.61M 2.26%
+9,811
New +$1.57M
2015 Q2
0 quarters
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$13.6B
$1.57M 2.21%
8,913
-937
-10% -$168K
2015 Q1
1 quarter
TEVA icon
14
Teva Pharmaceutical Industries Limited
TEVA
$47.5B
$1.49M 2.09%
25,141
+9,832
+64% +$607K
2014 Q1
5 quarters
MIC icon
15
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$1.43M 2.02%
17,341
-2,557
-13% -$216K
2014 Q1
5 quarters
UHS icon
16
Universal Health Services
UHS
$11B
$1.42M 2%
+9,988
New +$1.25M
2015 Q2
0 quarters
META icon
17
Meta Platforms (Facebook)
META
$1.88T
$1.36M 1.91%
15,857
+4,417
+39% +$361K
2013 Q4
6 quarters
THC icon
18
Tenet Healthcare
THC
$21.9B
$1.3M 1.84%
22,540
-7,456
-25% -$381K
2013 Q3
7 quarters
HOLX icon
19
DELISTED
Hologic
HOLX
$1.27M 1.79%
33,402
-21,569
-39% -$755K
2014 Q3
3 quarters
AAPL icon
20
Apple
AAPL
$5.01T
$1.26M 1.78%
40,292
+13,552
+51% +$433K
2015 Q1
1 quarter
EXP icon
21
Eagle Materials
EXP
$5.01B
$1.2M 1.69%
15,745
+8,585
+120% +$709K
2015 Q1
1 quarter
VMW
22
DELISTED
VMware, Inc
VMW
$1.13M 1.59%
+13,180
New +$1.15M
2015 Q2
0 quarters
PANW icon
23
Palo Alto Networks
PANW
$307B
$1.09M 1.53%
37,314
-9,348
-20% -$250K
2014 Q2
4 quarters
MDCO
24
DELISTED
Medicines Co
MDCO
$1.07M 1.51%
+37,510
New +$1.04M
2015 Q2
0 quarters
UNH icon
25
UnitedHealth
UNH
$355B
$995K 1.4%
8,152
-6,609
-45% -$782K
2014 Q4
2 quarters
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Partner Investment Management held 121 positions worth $71.1M, up 7.1% from $66.4M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Partner Investment Management's Q2 2015 filing shows 39 new, 28 increased, 18 reduced and 35 closed positions. Its largest new stake was Aetna Inc: 14,390 shares worth $1.83M. The largest sale was Bausch Health, an estimated $1.68M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Partner Investment Management's largest Q2 2015 buy was Aetna Inc: 14,390 shares worth $1.83M.
  • Partner Investment Management added most to HCA Healthcare in Q2 2015, an estimated $1.56M increase.
  • Partner Investment Management's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $1.68M.
  • Partner Investment Management fully exited McKesson in Q2 2015, selling an estimated $1.54M.
  • Partner Investment Management's ten largest holdings make up 34% of its $71.1M portfolio in Q2 2015.
  • Partner Investment Management opened 39 new positions and closed 35 in Q2 2015.
  • Partner Investment Management's portfolio value rose 7.1% quarter-over-quarter to $71.1M.

Based on Partner Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.